Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships

Abstract

The results provide strong evidence that imipramine has specific, clinically significant effects in this disorder, with practical implications for target doses and optimal plasma concentrations, and suggest that different mechanisms underlie the drug's antipanic and antiphobic effects.